article thumbnail

Achieve competitive advantage in precision medicine with IBM and Amazon Omics

IBM Big Data Hub

We are at an inflection point, where we have witnessed 100,000-fold reduction in cost since the human genome was first sequenced in 2001. High-throughput sequencing technology, notably next generation sequencing (NGS) platforms, has led to a multiomics revolution.